Goserelin acetate - Breast cancer
You are here : Home > Formulary Search > Goserelin acetate - Breast cancer
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Goserelin acetate
Indication :
Breast cancer
Group Name :
Keywords :
Brand Names Include :
Zoladex LA
Important Information :
Latest Additions Date From :
13 Nov 2025
Latest Additions Date To :
13 Dec 2025
Guidelines :
Supporting Documents :
0
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed a change in traffic light status for patients being treated for Breast Cancer.
Goserelin for this indication will be considered BLUE (with specialist team initiation). The specialist team will prescribe and administer the 1st injection prior to transfer of care to primary care colleagues.
A Locally Commissioned Service (LCS) is available.
Other Indications
Below are listed other indications that Goserelin acetate is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Breast cancer.